CA2382495A1 - Polypeptides secretes et transmembranaires et acides nucleiques les codant - Google Patents

Info

Publication number

CA2382495A1

CA2382495A1 CA002382495A CA2382495A CA2382495A1 CA 2382495 A1 CA2382495 A1 CA 2382495A1 CA 002382495 A CA002382495 A CA 002382495A CA 2382495 A CA2382495 A CA 2382495A CA 2382495 A1 CA2382495 A1 CA 2382495A1

Authority

CA

Canada

Prior art keywords

polypeptide

seq

sequence

amino acid

protein

Prior art date

1997-09-17

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 702
• 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 696
• 229920001184 polypeptide Polymers 0.000 title claims abstract description 681
• 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 213
• 102000039446 nucleic acids Human genes 0.000 title claims abstract description 149
• 108020004707 nucleic acids Proteins 0.000 title claims abstract description 149
• 238000000034 method Methods 0.000 claims abstract description 52
• 239000013598 vector Substances 0.000 claims abstract description 8
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 155
• 210000004027 cell Anatomy 0.000 claims description 144
• 108020004414 DNA Proteins 0.000 claims description 139
• 239000002773 nucleotide Substances 0.000 claims description 91
• 125000003729 nucleotide group Chemical group 0.000 claims description 91
• 230000000295 complement effect Effects 0.000 claims description 73
• 108091026890 Coding region Proteins 0.000 claims description 70
• 230000014509 gene expression Effects 0.000 claims description 22
• 230000008569 process Effects 0.000 claims description 14
• 108060003951 Immunoglobulin Proteins 0.000 claims description 3
• 238000004113 cell culture Methods 0.000 claims description 3
• 210000004978 chinese hamster ovary cell Anatomy 0.000 claims description 3
• 102000018358 immunoglobulin Human genes 0.000 claims description 3
• 241000588724 Escherichia coli Species 0.000 claims description 2
• 238000012258 culturing Methods 0.000 claims description 2
• 210000005253 yeast cell Anatomy 0.000 claims 1
• 108090000623 proteins and genes Proteins 0.000 description 258
• 102000004169 proteins and genes Human genes 0.000 description 248
• 235000018102 proteins Nutrition 0.000 description 241
• 239000002299 complementary DNA Substances 0.000 description 123
• 235000001014 amino acid Nutrition 0.000 description 103
• 229940024606 amino acid Drugs 0.000 description 98
• 150000001413 amino acids Chemical class 0.000 description 94
• 108091028043 Nucleic acid sequence Proteins 0.000 description 87
• 102000005962 receptors Human genes 0.000 description 68
• 108020003175 receptors Proteins 0.000 description 68
• 210000004901 leucine-rich repeat Anatomy 0.000 description 65
• 125000000539 amino acid group Chemical group 0.000 description 64
• 206010028980 Neoplasm Diseases 0.000 description 61
• 239000012528 membrane Substances 0.000 description 55
• 210000004379 membrane Anatomy 0.000 description 54
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 50
• 101800003838 Epidermal growth factor Proteins 0.000 description 49
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 49
• 229940116977 epidermal growth factor Drugs 0.000 description 49
• 230000006870 function Effects 0.000 description 49
• 230000004850 protein–protein interaction Effects 0.000 description 42
• 239000003102 growth factor Substances 0.000 description 40
• 230000027455 binding Effects 0.000 description 39
• 108091007433 antigens Proteins 0.000 description 36
• 102000036639 antigens Human genes 0.000 description 36
• 239000000427 antigen Substances 0.000 description 34
• 238000012216 screening Methods 0.000 description 34
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 33
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 33
• 201000011510 cancer Diseases 0.000 description 32
• 238000012512 characterization method Methods 0.000 description 31
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 30
• 230000001413 cellular effect Effects 0.000 description 29
• 238000011282 treatment Methods 0.000 description 27
• 241000282414 Homo sapiens Species 0.000 description 25
• 230000000694 effects Effects 0.000 description 25
• 230000007246 mechanism Effects 0.000 description 25
• 210000001519 tissue Anatomy 0.000 description 24
• 102000004190 Enzymes Human genes 0.000 description 22
• 108090000790 Enzymes Proteins 0.000 description 22
• 229940088598 enzyme Drugs 0.000 description 22
• 230000029663 wound healing Effects 0.000 description 22
• 230000004069 differentiation Effects 0.000 description 21
• 201000010099 disease Diseases 0.000 description 21
• 239000002523 lectin Substances 0.000 description 21
• 239000002243 precursor Substances 0.000 description 21
• 239000000523 sample Substances 0.000 description 21
• 229940126864 fibroblast growth factor Drugs 0.000 description 19
• 210000002569 neuron Anatomy 0.000 description 19
• 108010035532 Collagen Proteins 0.000 description 18
• 102000008186 Collagen Human genes 0.000 description 18
• 230000015572 biosynthetic process Effects 0.000 description 18
• 229920001436 collagen Polymers 0.000 description 18
• 230000001105 regulatory effect Effects 0.000 description 18
• 210000000130 stem cell Anatomy 0.000 description 18
• 108020004511 Recombinant DNA Proteins 0.000 description 17
• 238000004590 computer program Methods 0.000 description 17
• 230000012010 growth Effects 0.000 description 17
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 16
• 230000003993 interaction Effects 0.000 description 16
• 238000002864 sequence alignment Methods 0.000 description 16
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 15
• 102000004856 Lectins Human genes 0.000 description 15
• 108090001090 Lectins Proteins 0.000 description 15
• 230000035755 proliferation Effects 0.000 description 15
• 102000001301 EGF receptor Human genes 0.000 description 14
• 108060006698 EGF receptor Proteins 0.000 description 14
• 108010092694 L-Selectin Proteins 0.000 description 14
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
• 102000016611 Proteoglycans Human genes 0.000 description 13
• 108010067787 Proteoglycans Proteins 0.000 description 13
• SQEHCNOBYLQFTG-UHFFFAOYSA-M lithium;thiophene-2-carboxylate Chemical compound [Li+].[O-]C(=O)C1=CC=CS1 SQEHCNOBYLQFTG-UHFFFAOYSA-M 0.000 description 13
• 230000017423 tissue regeneration Effects 0.000 description 13
• 102000016551 L-selectin Human genes 0.000 description 12
• 239000002253 acid Substances 0.000 description 12
• 230000021164 cell adhesion Effects 0.000 description 12
• 210000003169 central nervous system Anatomy 0.000 description 12
• 230000018109 developmental process Effects 0.000 description 12
• 238000003745 diagnosis Methods 0.000 description 12
• 102100026423 Adhesion G protein-coupled receptor E5 Human genes 0.000 description 11
• 101000718243 Homo sapiens Adhesion G protein-coupled receptor E5 Proteins 0.000 description 11
• 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 description 11
• 108010079274 Thrombomodulin Proteins 0.000 description 11
• 230000004913 activation Effects 0.000 description 11
• 230000006907 apoptotic process Effects 0.000 description 11
• 210000004369 blood Anatomy 0.000 description 11
• 239000008280 blood Substances 0.000 description 11
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 11
• 238000011161 development Methods 0.000 description 11
• 230000001404 mediated effect Effects 0.000 description 11
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 10
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 10
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 10
• 102000003800 Selectins Human genes 0.000 description 10
• 108090000184 Selectins Proteins 0.000 description 10
• 102100026966 Thrombomodulin Human genes 0.000 description 10
• 239000005557 antagonist Substances 0.000 description 10
• 230000004071 biological effect Effects 0.000 description 10
• 210000001772 blood platelet Anatomy 0.000 description 10
• 239000012634 fragment Substances 0.000 description 10
• 102000006495 integrins Human genes 0.000 description 10
• 108010044426 integrins Proteins 0.000 description 10
• 239000003446 ligand Substances 0.000 description 10
• 230000035772 mutation Effects 0.000 description 10
• -1 survival factors Substances 0.000 description 10
• 102100033292 Leucine-rich repeat-containing protein 7 Human genes 0.000 description 9
• 101710148963 Leucine-rich repeat-containing protein 7 Proteins 0.000 description 9
• 108010035766 P-Selectin Proteins 0.000 description 9
• 102000035195 Peptidases Human genes 0.000 description 9
• 108091005804 Peptidases Proteins 0.000 description 9
• 108010076504 Protein Sorting Signals Proteins 0.000 description 9
• 230000009471 action Effects 0.000 description 9
• 208000035475 disorder Diseases 0.000 description 9
• 239000003623 enhancer Substances 0.000 description 9
• 210000002744 extracellular matrix Anatomy 0.000 description 9
• 230000000977 initiatory effect Effects 0.000 description 9
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 8
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 8
• 102000000844 Cell Surface Receptors Human genes 0.000 description 8
• 108010001857 Cell Surface Receptors Proteins 0.000 description 8
• 206010009944 Colon cancer Diseases 0.000 description 8
• 102000053602 DNA Human genes 0.000 description 8
• 102000004237 Decorin Human genes 0.000 description 8
• 108090000738 Decorin Proteins 0.000 description 8
• 108010013996 Fibromodulin Proteins 0.000 description 8
• 102000017177 Fibromodulin Human genes 0.000 description 8
• 102000000853 LDL receptors Human genes 0.000 description 8
• 108010001831 LDL receptors Proteins 0.000 description 8
• 102000004316 Oxidoreductases Human genes 0.000 description 8
• 108090000854 Oxidoreductases Proteins 0.000 description 8
• 150000001720 carbohydrates Chemical class 0.000 description 8
• 230000006378 damage Effects 0.000 description 8
• 210000002919 epithelial cell Anatomy 0.000 description 8
• 210000003734 kidney Anatomy 0.000 description 8
• 210000004698 lymphocyte Anatomy 0.000 description 8
• 229930182817 methionine Natural products 0.000 description 8
• 230000003389 potentiating effect Effects 0.000 description 8
• 238000011160 research Methods 0.000 description 8
• 230000037390 scarring Effects 0.000 description 8
• 210000003491 skin Anatomy 0.000 description 8
• 230000000638 stimulation Effects 0.000 description 8
• 238000001356 surgical procedure Methods 0.000 description 8
• 230000004083 survival effect Effects 0.000 description 8
• 208000024827 Alzheimer disease Diseases 0.000 description 7
• 102100032912 CD44 antigen Human genes 0.000 description 7
• 108010024212 E-Selectin Proteins 0.000 description 7
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 7
• 101710201625 Leucine-rich protein Proteins 0.000 description 7
• 241000124008 Mammalia Species 0.000 description 7
• 241000699666 Mus <mouse, genus> Species 0.000 description 7
• 102100023472 P-selectin Human genes 0.000 description 7
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 7
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 7
• 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 7
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 7
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 7
• 208000027418 Wounds and injury Diseases 0.000 description 7
• 210000004556 brain Anatomy 0.000 description 7
• 235000014633 carbohydrates Nutrition 0.000 description 7
• 208000029742 colonic neoplasm Diseases 0.000 description 7
• 230000001419 dependent effect Effects 0.000 description 7
• 238000004519 manufacturing process Methods 0.000 description 7
• 108020003519 protein disulfide isomerase Proteins 0.000 description 7
• 230000004044 response Effects 0.000 description 7
• 102000014452 scavenger receptors Human genes 0.000 description 7
• 108010078070 scavenger receptors Proteins 0.000 description 7
• 230000001225 therapeutic effect Effects 0.000 description 7
• 102000007299 Amphiregulin Human genes 0.000 description 6
• 108010033760 Amphiregulin Proteins 0.000 description 6
• 102000003886 Glycoproteins Human genes 0.000 description 6
• 108090000288 Glycoproteins Proteins 0.000 description 6
• 108010052285 Membrane Proteins Proteins 0.000 description 6
• 241001465754 Metazoa Species 0.000 description 6
• 208000028389 Nerve injury Diseases 0.000 description 6
• 208000018737 Parkinson disease Diseases 0.000 description 6
• 208000037273 Pathologic Processes Diseases 0.000 description 6
• 108010009583 Transforming Growth Factors Proteins 0.000 description 6
• 102000009618 Transforming Growth Factors Human genes 0.000 description 6
• 230000002159 abnormal effect Effects 0.000 description 6
• 108010061314 alpha-L-Fucosidase Proteins 0.000 description 6
• 102000012086 alpha-L-Fucosidase Human genes 0.000 description 6
• 238000004458 analytical method Methods 0.000 description 6
• 230000033115 angiogenesis Effects 0.000 description 6
• 230000008827 biological function Effects 0.000 description 6
• 230000004663 cell proliferation Effects 0.000 description 6
• 230000002490 cerebral effect Effects 0.000 description 6
• 210000002808 connective tissue Anatomy 0.000 description 6
• 239000013078 crystal Substances 0.000 description 6
• 239000003814 drug Substances 0.000 description 6
• 102000013370 fibrillin Human genes 0.000 description 6
• 108060002895 fibrillin Proteins 0.000 description 6
• 210000002950 fibroblast Anatomy 0.000 description 6
• 230000002496 gastric effect Effects 0.000 description 6
• 208000031169 hemorrhagic disease Diseases 0.000 description 6
• 229940088597 hormone Drugs 0.000 description 6
• 238000001727 in vivo Methods 0.000 description 6
• 208000017169 kidney disease Diseases 0.000 description 6
• 238000012423 maintenance Methods 0.000 description 6
• 239000003226 mitogen Substances 0.000 description 6
• 230000000394 mitotic effect Effects 0.000 description 6
• 201000008383 nephritis Diseases 0.000 description 6
• 230000008764 nerve damage Effects 0.000 description 6
• 230000009054 pathological process Effects 0.000 description 6
• 230000037361 pathway Effects 0.000 description 6
• 230000008929 regeneration Effects 0.000 description 6
• 238000011069 regeneration method Methods 0.000 description 6
• 230000007727 signaling mechanism Effects 0.000 description 6
• 239000002904 solvent Substances 0.000 description 6
• 230000000946 synaptic effect Effects 0.000 description 6
• 201000001320 Atherosclerosis Diseases 0.000 description 5
• 208000001593 Bernard-Soulier syndrome Diseases 0.000 description 5
• 108090000342 C-Type Lectins Proteins 0.000 description 5
• 102000003930 C-Type Lectins Human genes 0.000 description 5
• 208000028702 Congenital thrombocyte disease Diseases 0.000 description 5
• 102100023471 E-selectin Human genes 0.000 description 5
• 102000001895 Gonadotropin Receptors Human genes 0.000 description 5
• 108010040490 Gonadotropin Receptors Proteins 0.000 description 5
• 206010061218 Inflammation Diseases 0.000 description 5
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 5
• 102000014429 Insulin-like growth factor Human genes 0.000 description 5
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
• 102000018697 Membrane Proteins Human genes 0.000 description 5
• 206010027476 Metastases Diseases 0.000 description 5
• 108010070047 Notch Receptors Proteins 0.000 description 5
• 101710141795 Ribonuclease inhibitor Proteins 0.000 description 5
• 102100037968 Ribonuclease inhibitor Human genes 0.000 description 5
• 239000000556 agonist Substances 0.000 description 5
• 230000033228 biological regulation Effects 0.000 description 5
• 230000010261 cell growth Effects 0.000 description 5
• 230000035605 chemotaxis Effects 0.000 description 5
• 235000012000 cholesterol Nutrition 0.000 description 5
• 238000003776 cleavage reaction Methods 0.000 description 5
• 230000024203 complement activation Effects 0.000 description 5
• 239000000539 dimer Substances 0.000 description 5
• 210000002889 endothelial cell Anatomy 0.000 description 5
• 102000006482 fibulin Human genes 0.000 description 5
• 108010044392 fibulin Proteins 0.000 description 5
• 101150011183 hcaR gene Proteins 0.000 description 5
• 239000005556 hormone Substances 0.000 description 5
• 238000009396 hybridization Methods 0.000 description 5
• 230000004054 inflammatory process Effects 0.000 description 5
• 239000003112 inhibitor Substances 0.000 description 5
• 230000002401 inhibitory effect Effects 0.000 description 5
• 208000014674 injury Diseases 0.000 description 5
• 208000028867 ischemia Diseases 0.000 description 5
• 108020004999 messenger RNA Proteins 0.000 description 5
• 239000000203 mixture Substances 0.000 description 5
• 230000001537 neural effect Effects 0.000 description 5
• 230000004770 neurodegeneration Effects 0.000 description 5
• 208000015122 neurodegenerative disease Diseases 0.000 description 5
• 230000005868 ontogenesis Effects 0.000 description 5
• 230000008506 pathogenesis Effects 0.000 description 5
• 230000007017 scission Effects 0.000 description 5
• 230000003248 secreting effect Effects 0.000 description 5
• 108010059841 serine carboxypeptidase Proteins 0.000 description 5
• 210000002966 serum Anatomy 0.000 description 5
• 230000011664 signaling Effects 0.000 description 5
• 230000004936 stimulating effect Effects 0.000 description 5
• 229960001134 von willebrand factor Drugs 0.000 description 5
• 102100026439 Adhesion G protein-coupled receptor E1 Human genes 0.000 description 4
• 108090000654 Bone morphogenetic protein 1 Proteins 0.000 description 4
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
• 108010006303 Carboxypeptidases Proteins 0.000 description 4
• 102000005367 Carboxypeptidases Human genes 0.000 description 4
• 201000009030 Carcinoma Diseases 0.000 description 4
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 4
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 4
• 108010069112 Complement System Proteins Proteins 0.000 description 4
• 102000000989 Complement System Proteins Human genes 0.000 description 4
• 102100027816 Cytotoxic and regulatory T-cell molecule Human genes 0.000 description 4
• 102000012545 EGF-like domains Human genes 0.000 description 4
• 108050002150 EGF-like domains Proteins 0.000 description 4
• 208000032843 Hemorrhage Diseases 0.000 description 4
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 101000718225 Homo sapiens Adhesion G protein-coupled receptor E1 Proteins 0.000 description 4
• 108010007622 LDL Lipoproteins Proteins 0.000 description 4
• 102000007330 LDL Lipoproteins Human genes 0.000 description 4
• 108091054455 MAP kinase family Proteins 0.000 description 4
• 102000043136 MAP kinase family Human genes 0.000 description 4
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 4
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 4
• 241000283973 Oryctolagus cuniculus Species 0.000 description 4
• 102100038411 Platelet glycoprotein V Human genes 0.000 description 4
• 101710195077 Platelet glycoprotein V Proteins 0.000 description 4
• 102000004079 Prolyl Hydroxylases Human genes 0.000 description 4
• 108010043005 Prolyl Hydroxylases Proteins 0.000 description 4
• 102100028927 Secretin receptor Human genes 0.000 description 4
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
• 206010048302 Tubulointerstitial nephritis Diseases 0.000 description 4
• 108010066342 Virus Receptors Proteins 0.000 description 4
• 102000018265 Virus Receptors Human genes 0.000 description 4
• 150000007513 acids Chemical class 0.000 description 4
• 230000001154 acute effect Effects 0.000 description 4
• 230000000692 anti-sense effect Effects 0.000 description 4
• 230000031018 biological processes and functions Effects 0.000 description 4
• 239000011575 calcium Substances 0.000 description 4
• 229910052791 calcium Inorganic materials 0.000 description 4
• 230000024245 cell differentiation Effects 0.000 description 4
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 4
• 230000001684 chronic effect Effects 0.000 description 4
• 108010072917 class-I restricted T cell-associated molecule Proteins 0.000 description 4
• 230000001054 cortical effect Effects 0.000 description 4
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
• 238000001514 detection method Methods 0.000 description 4
• 230000013020 embryo development Effects 0.000 description 4
• 210000002216 heart Anatomy 0.000 description 4
• 229920000669 heparin Polymers 0.000 description 4
• 229960002897 heparin Drugs 0.000 description 4
• 230000036737 immune function Effects 0.000 description 4
• 230000028709 inflammatory response Effects 0.000 description 4
• 201000006334 interstitial nephritis Diseases 0.000 description 4
• 230000003834 intracellular effect Effects 0.000 description 4
• 230000004068 intracellular signaling Effects 0.000 description 4
• 210000000265 leukocyte Anatomy 0.000 description 4
• 210000004072 lung Anatomy 0.000 description 4
• 210000001724 microfibril Anatomy 0.000 description 4
• 210000003098 myoblast Anatomy 0.000 description 4
• 230000001613 neoplastic effect Effects 0.000 description 4
• 210000005036 nerve Anatomy 0.000 description 4
• 230000000508 neurotrophic effect Effects 0.000 description 4
• 210000000440 neutrophil Anatomy 0.000 description 4
• 210000000496 pancreas Anatomy 0.000 description 4
• 230000001575 pathological effect Effects 0.000 description 4
• 230000002285 radioactive effect Effects 0.000 description 4
• 230000008439 repair process Effects 0.000 description 4
• 230000010410 reperfusion Effects 0.000 description 4
• 108700027603 secretin receptor Proteins 0.000 description 4
• 229910052708 sodium Inorganic materials 0.000 description 4
• 239000011734 sodium Substances 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 230000002459 sustained effect Effects 0.000 description 4
• 102000035160 transmembrane proteins Human genes 0.000 description 4
• 108091005703 transmembrane proteins Proteins 0.000 description 4
• 108010047303 von Willebrand Factor Proteins 0.000 description 4
• 102100036537 von Willebrand factor Human genes 0.000 description 4
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
• 108010059616 Activins Proteins 0.000 description 3
• 102000005606 Activins Human genes 0.000 description 3
• 102100028728 Bone morphogenetic protein 1 Human genes 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 206010006187 Breast cancer Diseases 0.000 description 3
• 208000026310 Breast neoplasm Diseases 0.000 description 3
• 102000027791 CD44 antigen Human genes 0.000 description 3
• 108091016585 CD44 antigen Proteins 0.000 description 3
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
• 206010010356 Congenital anomaly Diseases 0.000 description 3
• 101710195240 Cysteine-rich venom protein Proteins 0.000 description 3
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 3
• 108091060211 Expressed sequence tag Proteins 0.000 description 3
• 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 3
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 3
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 3
• 206010018338 Glioma Diseases 0.000 description 3
• 101001018384 Homo sapiens Matrilin-2 Proteins 0.000 description 3
• 102100028084 Hyaluronan and proteoglycan link protein 1 Human genes 0.000 description 3
• 101710191341 Hyaluronan and proteoglycan link protein 1 Proteins 0.000 description 3
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
• 108010004250 Inhibins Proteins 0.000 description 3
• 102000002746 Inhibins Human genes 0.000 description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
• 102000011965 Lipoprotein Receptors Human genes 0.000 description 3
• 108010061306 Lipoprotein Receptors Proteins 0.000 description 3
• 101100288960 Mus musculus Lefty1 gene Proteins 0.000 description 3
• 102000005650 Notch Receptors Human genes 0.000 description 3
• 108091034117 Oligonucleotide Proteins 0.000 description 3
• 108091000080 Phosphotransferase Proteins 0.000 description 3
• 239000004365 Protease Substances 0.000 description 3
• 101800004937 Protein C Proteins 0.000 description 3
• 102000017975 Protein C Human genes 0.000 description 3
• 102000001253 Protein Kinase Human genes 0.000 description 3
• 201000004681 Psoriasis Diseases 0.000 description 3
• 101000844718 Rattus norvegicus Deleted in malignant brain tumors 1 protein Proteins 0.000 description 3
• 101800001700 Saposin-D Proteins 0.000 description 3
• 208000006011 Stroke Diseases 0.000 description 3
• 108010008125 Tenascin Proteins 0.000 description 3
• 102000007000 Tenascin Human genes 0.000 description 3
• 102000002933 Thioredoxin Human genes 0.000 description 3
• 208000025865 Ulcer Diseases 0.000 description 3
• 206010046788 Uterine haemorrhage Diseases 0.000 description 3
• 239000000488 activin Substances 0.000 description 3
• 230000004075 alteration Effects 0.000 description 3
• 239000003098 androgen Substances 0.000 description 3
• 239000003963 antioxidant agent Substances 0.000 description 3
• 235000006708 antioxidants Nutrition 0.000 description 3
• 238000013459 approach Methods 0.000 description 3
• 230000003305 autocrine Effects 0.000 description 3
• 208000034158 bleeding Diseases 0.000 description 3
• 230000000740 bleeding effect Effects 0.000 description 3
• 230000023555 blood coagulation Effects 0.000 description 3
• 239000003114 blood coagulation factor Substances 0.000 description 3
• 210000004204 blood vessel Anatomy 0.000 description 3
• 210000001124 body fluid Anatomy 0.000 description 3
• 239000010839 body fluid Substances 0.000 description 3
• 210000000988 bone and bone Anatomy 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 230000009134 cell regulation Effects 0.000 description 3
• 230000033077 cellular process Effects 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 238000006243 chemical reaction Methods 0.000 description 3
• 210000001072 colon Anatomy 0.000 description 3
• 102000006834 complement receptors Human genes 0.000 description 3
• 108010047295 complement receptors Proteins 0.000 description 3
• 235000018417 cysteine Nutrition 0.000 description 3
• 230000003247 decreasing effect Effects 0.000 description 3
• 229960000633 dextran sulfate Drugs 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 230000002124 endocrine Effects 0.000 description 3
• 210000004696 endometrium Anatomy 0.000 description 3
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 3
• 230000002255 enzymatic effect Effects 0.000 description 3
• 230000036541 health Effects 0.000 description 3
• 102000050569 human MATN2 Human genes 0.000 description 3
• 238000007901 in situ hybridization Methods 0.000 description 3
• 238000011065 in-situ storage Methods 0.000 description 3
• 230000001965 increasing effect Effects 0.000 description 3
• 239000000893 inhibin Substances 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 230000008611 intercellular interaction Effects 0.000 description 3
• 102000035110 latrophilin Human genes 0.000 description 3
• 108091005543 latrophilin Proteins 0.000 description 3
• 239000011159 matrix material Substances 0.000 description 3
• 230000009401 metastasis Effects 0.000 description 3
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 3
• 230000005012 migration Effects 0.000 description 3
• 238000013508 migration Methods 0.000 description 3
• 208000010125 myocardial infarction Diseases 0.000 description 3
• 230000017074 necrotic cell death Effects 0.000 description 3
• 210000000653 nervous system Anatomy 0.000 description 3
• 238000007254 oxidation reaction Methods 0.000 description 3
• 230000036542 oxidative stress Effects 0.000 description 3
• 230000003076 paracrine Effects 0.000 description 3
• 230000002093 peripheral effect Effects 0.000 description 3
• 230000026731 phosphorylation Effects 0.000 description 3
• 238000006366 phosphorylation reaction Methods 0.000 description 3
• 102000020233 phosphotransferase Human genes 0.000 description 3
• 108050009312 plexin Proteins 0.000 description 3
• 102000002022 plexin Human genes 0.000 description 3
• 230000035935 pregnancy Effects 0.000 description 3
• 230000002265 prevention Effects 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 210000002307 prostate Anatomy 0.000 description 3
• 229960000856 protein c Drugs 0.000 description 3
• 230000009822 protein phosphorylation Effects 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 239000003642 reactive oxygen metabolite Substances 0.000 description 3
• 108010086642 reticulocalbin Proteins 0.000 description 3
• 206010039073 rheumatoid arthritis Diseases 0.000 description 3
• 230000019491 signal transduction Effects 0.000 description 3
• 239000001509 sodium citrate Substances 0.000 description 3
• 108060008226 thioredoxin Proteins 0.000 description 3
• 238000013518 transcription Methods 0.000 description 3
• 230000035897 transcription Effects 0.000 description 3
• 238000010361 transduction Methods 0.000 description 3
• 230000026683 transduction Effects 0.000 description 3
• 230000001131 transforming effect Effects 0.000 description 3
• 230000032258 transport Effects 0.000 description 3
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
• 230000036269 ulceration Effects 0.000 description 3
• 210000002700 urine Anatomy 0.000 description 3
• 238000005406 washing Methods 0.000 description 3
• 108010051457 Acid Phosphatase Proteins 0.000 description 2
• 102000013563 Acid Phosphatase Human genes 0.000 description 2
• 102100040023 Adhesion G-protein coupled receptor G6 Human genes 0.000 description 2
• 108010005853 Anti-Mullerian Hormone Proteins 0.000 description 2
• 239000004475 Arginine Substances 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 241000972773 Aulopiformes Species 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
• 102000004506 Blood Proteins Human genes 0.000 description 2
• 108010017384 Blood Proteins Proteins 0.000 description 2
• 201000006474 Brain Ischemia Diseases 0.000 description 2
• 206010008120 Cerebral ischaemia Diseases 0.000 description 2
• 208000017667 Chronic Disease Diseases 0.000 description 2
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
• 102000012422 Collagen Type I Human genes 0.000 description 2
• 108010022452 Collagen Type I Proteins 0.000 description 2
• 102000016574 Complement C3-C5 Convertases Human genes 0.000 description 2
• 108010067641 Complement C3-C5 Convertases Proteins 0.000 description 2
• 102000016550 Complement Factor H Human genes 0.000 description 2
• 208000032170 Congenital Abnormalities Diseases 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 208000002249 Diabetes Complications Diseases 0.000 description 2
• 206010012655 Diabetic complications Diseases 0.000 description 2
• 102000015689 E-Selectin Human genes 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 201000009273 Endometriosis Diseases 0.000 description 2
• 102100028072 Fibroblast growth factor 4 Human genes 0.000 description 2
• 108090000380 Fibroblast growth factor 5 Proteins 0.000 description 2
• 102100028073 Fibroblast growth factor 5 Human genes 0.000 description 2
• 108090000382 Fibroblast growth factor 6 Proteins 0.000 description 2
• 102100028075 Fibroblast growth factor 6 Human genes 0.000 description 2
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 2
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 2
• 102100037680 Fibroblast growth factor 8 Human genes 0.000 description 2
• 108010067306 Fibronectins Proteins 0.000 description 2
• 102000016359 Fibronectins Human genes 0.000 description 2
• 206010016654 Fibrosis Diseases 0.000 description 2
• 101710170731 Fibulin-1 Proteins 0.000 description 2
• 102100031812 Fibulin-1 Human genes 0.000 description 2
• 241000287828 Gallus gallus Species 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 108010090293 Growth Differentiation Factor 3 Proteins 0.000 description 2
• 102000004858 Growth differentiation factor-9 Human genes 0.000 description 2
• 108090001086 Growth differentiation factor-9 Proteins 0.000 description 2
• 102100035364 Growth/differentiation factor 3 Human genes 0.000 description 2
• 208000013875 Heart injury Diseases 0.000 description 2
• NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
• 108700005087 Homeobox Genes Proteins 0.000 description 2
• 101100378639 Homo sapiens ADGRG6 gene Proteins 0.000 description 2
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
• 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 2
• 206010020772 Hypertension Diseases 0.000 description 2
• 206010062767 Hypophysitis Diseases 0.000 description 2
• OUBORTRIKPEZMG-UHFFFAOYSA-N INT-2 Chemical compound Nc1c(ncn1-c1ccc(F)cc1)C(=N)C#N OUBORTRIKPEZMG-UHFFFAOYSA-N 0.000 description 2
• 102000000589 Interleukin-1 Human genes 0.000 description 2
• 108010002352 Interleukin-1 Proteins 0.000 description 2
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
• SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical group C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
• 102100033467 L-selectin Human genes 0.000 description 2
• 108010085895 Laminin Proteins 0.000 description 2
• 102000007547 Laminin Human genes 0.000 description 2
• 102100022170 Leucine-rich repeats and immunoglobulin-like domains protein 1 Human genes 0.000 description 2
• 101710180792 Leucine-rich repeats and immunoglobulin-like domains protein 1 Proteins 0.000 description 2
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
• 239000004472 Lysine Substances 0.000 description 2
• 101100378640 Mus musculus Adgrg6 gene Proteins 0.000 description 2
• 241000700562 Myxoma virus Species 0.000 description 2
• 102000003945 NF-kappa B Human genes 0.000 description 2
• 108010057466 NF-kappa B Proteins 0.000 description 2
• 206010028851 Necrosis Diseases 0.000 description 2
• 206010051606 Necrotising colitis Diseases 0.000 description 2
• 241000244206 Nematoda Species 0.000 description 2
• 108090000189 Neuropeptides Proteins 0.000 description 2
• 102100037369 Nidogen-1 Human genes 0.000 description 2
• 239000000020 Nitrocellulose Substances 0.000 description 2
• 238000000636 Northern blotting Methods 0.000 description 2
• 239000004677 Nylon Substances 0.000 description 2
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
• 108700020796 Oncogene Proteins 0.000 description 2
• 206010053159 Organ failure Diseases 0.000 description 2
• 102000008212 P-Selectin Human genes 0.000 description 2
• 206010057249 Phagocytosis Diseases 0.000 description 2
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
• 102100029740 Poliovirus receptor Human genes 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 101800001357 Potential peptide Proteins 0.000 description 2
• 102400000745 Potential peptide Human genes 0.000 description 2
• 206010063493 Premature ageing Diseases 0.000 description 2
• 208000032038 Premature aging Diseases 0.000 description 2
• 102100020847 Protein FosB Human genes 0.000 description 2
• 108010029485 Protein Isoforms Proteins 0.000 description 2
• 102000001708 Protein Isoforms Human genes 0.000 description 2
• 229940096437 Protein S Drugs 0.000 description 2
• 108010066124 Protein S Proteins 0.000 description 2
• 102000052575 Proto-Oncogene Human genes 0.000 description 2
• 108700020978 Proto-Oncogene Proteins 0.000 description 2
• 241000700564 Rabbit fibroma virus Species 0.000 description 2
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
• 108091007187 Reductases Proteins 0.000 description 2
• 238000012300 Sequence Analysis Methods 0.000 description 2
• 108010032838 Sialoglycoproteins Proteins 0.000 description 2
• 102000007365 Sialoglycoproteins Human genes 0.000 description 2
• 210000001744 T-lymphocyte Anatomy 0.000 description 2
• 108090000190 Thrombin Proteins 0.000 description 2
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
• 108010018242 Transcription Factor AP-1 Proteins 0.000 description 2
• 102000040945 Transcription factor Human genes 0.000 description 2
• 108091023040 Transcription factor Proteins 0.000 description 2
• 102100033470 Tubulointerstitial nephritis antigen Human genes 0.000 description 2
• 101710185398 Tubulointerstitial nephritis antigen Proteins 0.000 description 2
• 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 2
• 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 2
• 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 2
• 102100040613 Uromodulin Human genes 0.000 description 2
• 108010027007 Uromodulin Proteins 0.000 description 2
• 241000700618 Vaccinia virus Species 0.000 description 2
• 101000926072 Varicella-zoster virus (strain Dumas) Envelope glycoprotein C Proteins 0.000 description 2
• 208000024248 Vascular System injury Diseases 0.000 description 2
• 208000012339 Vascular injury Diseases 0.000 description 2
• 208000036142 Viral infection Diseases 0.000 description 2
• 241000700605 Viruses Species 0.000 description 2
• 229930003448 Vitamin K Natural products 0.000 description 2
• 102100028885 Vitamin K-dependent protein S Human genes 0.000 description 2
• 208000025337 Vulvar squamous cell carcinoma Diseases 0.000 description 2
• 206010052428 Wound Diseases 0.000 description 2
• 241000269370 Xenopus <genus> Species 0.000 description 2
• 101001060278 Xenopus laevis Fibroblast growth factor 3 Proteins 0.000 description 2
• 201000008629 Zollinger-Ellison syndrome Diseases 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 239000000853 adhesive Substances 0.000 description 2
• 230000001070 adhesive effect Effects 0.000 description 2
• 230000001919 adrenal effect Effects 0.000 description 2
• 230000032683 aging Effects 0.000 description 2
• 210000004381 amniotic fluid Anatomy 0.000 description 2
• 239000000868 anti-mullerian hormone Substances 0.000 description 2
• 239000003146 anticoagulant agent Substances 0.000 description 2
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
• 210000001130 astrocyte Anatomy 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 230000007698 birth defect Effects 0.000 description 2
• 229940019700 blood coagulation factors Drugs 0.000 description 2
• 230000004221 bone function Effects 0.000 description 2
• 210000000465 brunner gland Anatomy 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 210000004899 c-terminal region Anatomy 0.000 description 2
• 238000004422 calculation algorithm Methods 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 210000000845 cartilage Anatomy 0.000 description 2
• 230000005859 cell recognition Effects 0.000 description 2
• 210000001638 cerebellum Anatomy 0.000 description 2
• 210000003710 cerebral cortex Anatomy 0.000 description 2
• 206010008118 cerebral infarction Diseases 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• 210000001612 chondrocyte Anatomy 0.000 description 2
• 208000037976 chronic inflammation Diseases 0.000 description 2
• 230000006020 chronic inflammation Effects 0.000 description 2
• 208000020832 chronic kidney disease Diseases 0.000 description 2
• 239000000356 contaminant Substances 0.000 description 2
• 210000000399 corneal endothelial cell Anatomy 0.000 description 2
• 210000003618 cortical neuron Anatomy 0.000 description 2
• 210000000695 crystalline len Anatomy 0.000 description 2
• 231100000433 cytotoxic Toxicity 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 239000003145 cytotoxic factor Substances 0.000 description 2
• 230000005016 dendritic process Effects 0.000 description 2
• 230000030609 dephosphorylation Effects 0.000 description 2
• 238000006209 dephosphorylation reaction Methods 0.000 description 2
• 210000004207 dermis Anatomy 0.000 description 2
• 230000009547 development abnormality Effects 0.000 description 2
• 239000000032 diagnostic agent Substances 0.000 description 2
• 229940039227 diagnostic agent Drugs 0.000 description 2
• 230000003828 downregulation Effects 0.000 description 2
• 238000013399 early diagnosis Methods 0.000 description 2
• 210000003981 ectoderm Anatomy 0.000 description 2
• 230000002500 effect on skin Effects 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 230000007368 endocrine function Effects 0.000 description 2
• 230000012202 endocytosis Effects 0.000 description 2
• 230000002357 endometrial effect Effects 0.000 description 2
• 210000003038 endothelium Anatomy 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• 230000003176 fibrotic effect Effects 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
• 201000000052 gastrinoma Diseases 0.000 description 2
• 210000005095 gastrointestinal system Anatomy 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 230000004077 genetic alteration Effects 0.000 description 2
• 231100000118 genetic alteration Toxicity 0.000 description 2
• 230000010005 growth-factor like effect Effects 0.000 description 2
• 210000003780 hair follicle Anatomy 0.000 description 2
• 208000019622 heart disease Diseases 0.000 description 2
• 108010037896 heparin-binding hemagglutinin Proteins 0.000 description 2
• 210000001320 hippocampus Anatomy 0.000 description 2
• 239000000710 homodimer Substances 0.000 description 2
• 230000003054 hormonal effect Effects 0.000 description 2
• 235000020256 human milk Nutrition 0.000 description 2
• 210000004251 human milk Anatomy 0.000 description 2
• 229920002674 hyaluronan Polymers 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 230000033444 hydroxylation Effects 0.000 description 2
• 238000005805 hydroxylation reaction Methods 0.000 description 2
• 238000009802 hysterectomy Methods 0.000 description 2
• 230000028993 immune response Effects 0.000 description 2
• 230000036039 immunity Effects 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 208000000509 infertility Diseases 0.000 description 2
• 230000036512 infertility Effects 0.000 description 2
• 231100000535 infertility Toxicity 0.000 description 2
• 208000027866 inflammatory disease Diseases 0.000 description 2
• 230000004941 influx Effects 0.000 description 2
• ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 2
• 230000035992 intercellular communication Effects 0.000 description 2
• 210000002510 keratinocyte Anatomy 0.000 description 2
• 230000003907 kidney function Effects 0.000 description 2
• 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
• 108700041430 link Proteins 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 210000003141 lower extremity Anatomy 0.000 description 2
• 210000001165 lymph node Anatomy 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• 230000036210 malignancy Effects 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 210000003716 mesoderm Anatomy 0.000 description 2
• 230000002297 mitogenic effect Effects 0.000 description 2
• 208000008588 molluscum contagiosum Diseases 0.000 description 2
• 239000000178 monomer Substances 0.000 description 2
• 210000004877 mucosa Anatomy 0.000 description 2
• 230000009854 mucosal lesion Effects 0.000 description 2
• 210000004165 myocardium Anatomy 0.000 description 2
• 208000004995 necrotizing enterocolitis Diseases 0.000 description 2
• 210000000933 neural crest Anatomy 0.000 description 2
• 230000007472 neurodevelopment Effects 0.000 description 2
• 210000004498 neuroglial cell Anatomy 0.000 description 2
• 230000003227 neuromodulating effect Effects 0.000 description 2
• 230000014511 neuron projection development Effects 0.000 description 2
• 230000003472 neutralizing effect Effects 0.000 description 2
• 108010008217 nidogen Proteins 0.000 description 2
• 229920001220 nitrocellulos Polymers 0.000 description 2
• 230000000263 nonmitogenic effect Effects 0.000 description 2
• 229920001778 nylon Polymers 0.000 description 2
• 210000004248 oligodendroglia Anatomy 0.000 description 2
• 239000002751 oligonucleotide probe Substances 0.000 description 2
• 150000002482 oligosaccharides Polymers 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 210000000963 osteoblast Anatomy 0.000 description 2
• 230000003647 oxidation Effects 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• 210000001819 pancreatic juice Anatomy 0.000 description 2
• 239000000813 peptide hormone Substances 0.000 description 2
• 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 description 2
• 230000008782 phagocytosis Effects 0.000 description 2
• 239000012071 phase Substances 0.000 description 2
• 208000028591 pheochromocytoma Diseases 0.000 description 2
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
• SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
• 230000000704 physical effect Effects 0.000 description 2
• 230000001766 physiological effect Effects 0.000 description 2
• 210000003635 pituitary gland Anatomy 0.000 description 2
• 108010025221 plasma protein Z Proteins 0.000 description 2
• 230000004983 pleiotropic effect Effects 0.000 description 2
• 108010048507 poliovirus receptor Proteins 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 102000040430 polynucleotide Human genes 0.000 description 2
• 108091033319 polynucleotide Proteins 0.000 description 2
• 239000002157 polynucleotide Substances 0.000 description 2
• 238000004321 preservation Methods 0.000 description 2
• 238000004393 prognosis Methods 0.000 description 2
• 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
• 108010077112 prolyl-proline Proteins 0.000 description 2
• 210000004908 prostatic fluid Anatomy 0.000 description 2
• 230000013777 protein digestion Effects 0.000 description 2
• 108060006633 protein kinase Proteins 0.000 description 2
• 238000006479 redox reaction Methods 0.000 description 2
• 230000001603 reducing effect Effects 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 210000005084 renal tissue Anatomy 0.000 description 2
• 238000002271 resection Methods 0.000 description 2
• 230000000717 retained effect Effects 0.000 description 2
• 210000001525 retina Anatomy 0.000 description 2
• 108010038196 saccharide-binding proteins Proteins 0.000 description 2
• 210000003296 saliva Anatomy 0.000 description 2
• 210000003079 salivary gland Anatomy 0.000 description 2
• 235000019515 salmon Nutrition 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 208000017520 skin disease Diseases 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
• 239000001488 sodium phosphate Substances 0.000 description 2
• 229910000162 sodium phosphate Inorganic materials 0.000 description 2
• 206010041823 squamous cell carcinoma Diseases 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 230000001629 suppression Effects 0.000 description 2
• 238000003786 synthesis reaction Methods 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 229960004072 thrombin Drugs 0.000 description 2
• 210000001685 thyroid gland Anatomy 0.000 description 2
• 229960000187 tissue plasminogen activator Drugs 0.000 description 2
• 239000003053 toxin Substances 0.000 description 2
• 231100000765 toxin Toxicity 0.000 description 2
• 108700012359 toxins Proteins 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 230000014616 translation Effects 0.000 description 2
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
• 210000004881 tumor cell Anatomy 0.000 description 2
• 241000701161 unidentified adenovirus Species 0.000 description 2
• 229960005356 urokinase Drugs 0.000 description 2
• 210000004291 uterus Anatomy 0.000 description 2
• 210000003556 vascular endothelial cell Anatomy 0.000 description 2
• 210000004509 vascular smooth muscle cell Anatomy 0.000 description 2
• 230000007998 vessel formation Effects 0.000 description 2
• 230000009385 viral infection Effects 0.000 description 2
• 235000019168 vitamin K Nutrition 0.000 description 2
• 239000011712 vitamin K Substances 0.000 description 2
• 150000003721 vitamin K derivatives Chemical class 0.000 description 2
• 229940046010 vitamin k Drugs 0.000 description 2
• 210000001849 von ebner gland Anatomy 0.000 description 2
• 230000037314 wound repair Effects 0.000 description 2
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
• KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
• LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 1
• GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
• QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
• 210000002925 A-like Anatomy 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
• 208000009304 Acute Kidney Injury Diseases 0.000 description 1
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 102100036601 Aggrecan core protein Human genes 0.000 description 1
• 108010067219 Aggrecans Proteins 0.000 description 1
• 208000000884 Airway Obstruction Diseases 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 101710145634 Antigen 1 Proteins 0.000 description 1
• 108010071619 Apolipoproteins Proteins 0.000 description 1
• 102000007592 Apolipoproteins Human genes 0.000 description 1
• 200000000007 Arterial disease Diseases 0.000 description 1
• 206010003210 Arteriosclerosis Diseases 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
• 206010003694 Atrophy Diseases 0.000 description 1
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 1
• 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
• 102000004152 Bone morphogenetic protein 1 Human genes 0.000 description 1
• 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
• 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 102100024210 CD166 antigen Human genes 0.000 description 1
• 101100156752 Caenorhabditis elegans cwn-1 gene Proteins 0.000 description 1
• 101100074828 Caenorhabditis elegans lin-12 gene Proteins 0.000 description 1
• 108010001789 Calcitonin Receptors Proteins 0.000 description 1
• 102100038520 Calcitonin receptor Human genes 0.000 description 1
• BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
• 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
• 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 101710132601 Capsid protein Proteins 0.000 description 1
• 208000005623 Carcinogenesis Diseases 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 102000000503 Collagen Type II Human genes 0.000 description 1
• 108010041390 Collagen Type II Proteins 0.000 description 1
• 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
• 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
• 108010078015 Complement C3b Proteins 0.000 description 1
• 108010053085 Complement Factor H Proteins 0.000 description 1
• 102100025680 Complement decay-accelerating factor Human genes 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• 108010056643 Corticotropin-Releasing Hormone Receptors Proteins 0.000 description 1
• 241000709687 Coxsackievirus Species 0.000 description 1
• 101710169171 Cysteine-rich secretory protein Proteins 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• GJJFWGQGJJGJEO-UHFFFAOYSA-N Decarine Natural products C1=NC2=C3C=C4OCOC4=CC3=CC=C2C2=C1C(OC)=C(O)C=C2 GJJFWGQGJJGJEO-UHFFFAOYSA-N 0.000 description 1
• 239000004375 Dextrin Substances 0.000 description 1
• 229920001353 Dextrin Polymers 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
• 108010014258 Elastin Proteins 0.000 description 1
• 102000016942 Elastin Human genes 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 206010014733 Endometrial cancer Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 208000004145 Endometritis Diseases 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 102000018389 Exopeptidases Human genes 0.000 description 1
• 108010091443 Exopeptidases Proteins 0.000 description 1
• 206010015866 Extravasation Diseases 0.000 description 1
• 108091008794 FGF receptors Proteins 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
• 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
• 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 1
• 108090000381 Fibroblast growth factor 4 Proteins 0.000 description 1
• 102000003956 Fibroblast growth factor 8 Human genes 0.000 description 1
• 102100031813 Fibulin-2 Human genes 0.000 description 1
• 229920001917 Ficoll Polymers 0.000 description 1
• PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
• 102000000802 Galectin 3 Human genes 0.000 description 1
• 108010001517 Galectin 3 Proteins 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 229920002683 Glycosaminoglycan Polymers 0.000 description 1
• 108700023372 Glycosyltransferases Proteins 0.000 description 1
• 102000051366 Glycosyltransferases Human genes 0.000 description 1
• 108060003393 Granulin Proteins 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 208000037357 HIV infectious disease Diseases 0.000 description 1
• 102100031547 HLA class II histocompatibility antigen, DO alpha chain Human genes 0.000 description 1
• 208000028523 Hereditary Complement Deficiency disease Diseases 0.000 description 1
• 101000980840 Homo sapiens CD166 antigen Proteins 0.000 description 1
• 101000996823 Homo sapiens Cell surface A33 antigen Proteins 0.000 description 1
• 101000856022 Homo sapiens Complement decay-accelerating factor Proteins 0.000 description 1
• 101001060274 Homo sapiens Fibroblast growth factor 4 Proteins 0.000 description 1
• 101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 description 1
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
• 101001114057 Homo sapiens P antigen family member 1 Proteins 0.000 description 1
• 101000626163 Homo sapiens Tenascin-X Proteins 0.000 description 1
• 101000636213 Homo sapiens Transcriptional activator Myb Proteins 0.000 description 1
• 101000965724 Homo sapiens Volume-regulated anion channel subunit LRRC8B Proteins 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical group O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• 208000024781 Immune Complex disease Diseases 0.000 description 1
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
• 102000016844 Immunoglobulin-like domains Human genes 0.000 description 1
• 108050006430 Immunoglobulin-like domains Proteins 0.000 description 1
• 102100022339 Integrin alpha-L Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
• 208000003456 Juvenile Arthritis Diseases 0.000 description 1
• 206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 1
• 208000002260 Keloid Diseases 0.000 description 1
• 206010023421 Kidney fibrosis Diseases 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• 108010058141 LDL-Receptor Related Proteins Proteins 0.000 description 1
• 102000006259 LDL-Receptor Related Proteins Human genes 0.000 description 1
• 241000272168 Laridae Species 0.000 description 1
• 102000003752 Lipocalin 1 Human genes 0.000 description 1
• 108010057281 Lipocalin 1 Proteins 0.000 description 1
• 241000404158 Lonas Species 0.000 description 1
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
• 208000004852 Lung Injury Diseases 0.000 description 1
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 208000001826 Marfan syndrome Diseases 0.000 description 1
• 108010072582 Matrilin Proteins Proteins 0.000 description 1
• 102100033669 Matrilin-2 Human genes 0.000 description 1
• 208000026940 Microvillus inclusion disease Diseases 0.000 description 1
• 101100175313 Mus musculus Gdf3 gene Proteins 0.000 description 1
• 101001018383 Mus musculus Matrilin-2 Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
• 102000007339 Nerve Growth Factor Receptors Human genes 0.000 description 1
• 108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
• 102100021584 Neurturin Human genes 0.000 description 1
• 108010015406 Neurturin Proteins 0.000 description 1
• 241000269633 Notophthalmus viridescens Species 0.000 description 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• 240000007594 Oryza sativa Species 0.000 description 1
• 235000007164 Oryza sativa Nutrition 0.000 description 1
• 101710160107 Outer membrane protein A Proteins 0.000 description 1
• 102100023219 P antigen family member 1 Human genes 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 208000031481 Pathologic Constriction Diseases 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 241000425347 Phyla <beetle> Species 0.000 description 1
• 208000037062 Polyps Diseases 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 108010050808 Procollagen Proteins 0.000 description 1
• 102100041026 Procollagen C-endopeptidase enhancer 1 Human genes 0.000 description 1
• 101710087172 Procollagen C-endopeptidase enhancer 1 Proteins 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 108091005682 Receptor kinases Proteins 0.000 description 1
• 208000033626 Renal failure acute Diseases 0.000 description 1
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
• 108010086019 Secretin Proteins 0.000 description 1
• 102100037505 Secretin Human genes 0.000 description 1
• 108091058545 Secretory proteins Proteins 0.000 description 1
• 102000040739 Secretory proteins Human genes 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 108010036039 Serrate-Jagged Proteins Proteins 0.000 description 1
• 102000011842 Serrate-Jagged Proteins Human genes 0.000 description 1
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
• 208000028990 Skin injury Diseases 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• 102100025131 T-cell differentiation antigen CD6 Human genes 0.000 description 1
• 101100121955 Tanacetum cinerariifolium GLIP gene Proteins 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
• 206010069363 Traumatic lung injury Diseases 0.000 description 1
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
• 108070000030 Viral receptors Proteins 0.000 description 1
• 102100040982 Volume-regulated anion channel subunit LRRC8B Human genes 0.000 description 1
• 208000027276 Von Willebrand disease Diseases 0.000 description 1
• 108700020987 Wnt-1 Proteins 0.000 description 1
• 102000052547 Wnt-1 Human genes 0.000 description 1
• 101710185494 Zinc finger protein Proteins 0.000 description 1
• 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• 208000038016 acute inflammation Diseases 0.000 description 1
• 230000006022 acute inflammation Effects 0.000 description 1
• 201000011040 acute kidney failure Diseases 0.000 description 1
• 206010069351 acute lung injury Diseases 0.000 description 1
• 208000012998 acute renal failure Diseases 0.000 description 1
• 108010084938 adenovirus receptor Proteins 0.000 description 1
• 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
• 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• CMQZRJBJDCVIEY-JEOLMMCMSA-N alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical group O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)[C@@H]1NC(C)=O CMQZRJBJDCVIEY-JEOLMMCMSA-N 0.000 description 1
• NIGUVXFURDGQKZ-UQTBNESHSA-N alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O[C@]3(O[C@H]([C@H](NC(C)=O)[C@@H](O)C3)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O NIGUVXFURDGQKZ-UQTBNESHSA-N 0.000 description 1
• 230000001548 androgenic effect Effects 0.000 description 1
• 229940030486 androgens Drugs 0.000 description 1
• 239000002870 angiogenesis inducing agent Substances 0.000 description 1
• 238000002399 angioplasty Methods 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 229940127219 anticoagulant drug Drugs 0.000 description 1
• 230000006851 antioxidant defense Effects 0.000 description 1
• 229960004676 antithrombotic agent Drugs 0.000 description 1
• 238000003782 apoptosis assay Methods 0.000 description 1
• 208000011775 arteriosclerosis disease Diseases 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 230000003143 atherosclerotic effect Effects 0.000 description 1
• 230000037444 atrophy Effects 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
• 230000008275 binding mechanism Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 230000036770 blood supply Effects 0.000 description 1
• 238000006664 bond formation reaction Methods 0.000 description 1
• 229940098773 bovine serum albumin Drugs 0.000 description 1
• 239000008366 buffered solution Substances 0.000 description 1
• 229910001424 calcium ion Inorganic materials 0.000 description 1
• 230000036952 cancer formation Effects 0.000 description 1
• 102000023852 carbohydrate binding proteins Human genes 0.000 description 1
• 108091008400 carbohydrate binding proteins Proteins 0.000 description 1
• 231100000504 carcinogenesis Toxicity 0.000 description 1
• 230000009787 cardiac fibrosis Effects 0.000 description 1
• 230000022159 cartilage development Effects 0.000 description 1
• 230000001925 catabolic effect Effects 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 230000004956 cell adhesive effect Effects 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000008619 cell matrix interaction Effects 0.000 description 1
• 230000012292 cell migration Effects 0.000 description 1
• 230000017455 cell-cell adhesion Effects 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 230000007073 chemical hydrolysis Effects 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 210000000038 chest Anatomy 0.000 description 1
• 230000001713 cholinergic effect Effects 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 208000019069 chronic childhood arthritis Diseases 0.000 description 1
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
• 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
• 230000007882 cirrhosis Effects 0.000 description 1
• 208000019425 cirrhosis of liver Diseases 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 230000015271 coagulation Effects 0.000 description 1
• 238000005345 coagulation Methods 0.000 description 1
• 229940096422 collagen type i Drugs 0.000 description 1
• 229940047120 colony stimulating factors Drugs 0.000 description 1
• 201000002388 complement deficiency Diseases 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 208000029078 coronary artery disease Diseases 0.000 description 1
• 210000004351 coronary vessel Anatomy 0.000 description 1
• 239000002537 cosmetic Substances 0.000 description 1
• 238000002316 cosmetic surgery Methods 0.000 description 1
• 102000003675 cytokine receptors Human genes 0.000 description 1
• 108010057085 cytokine receptors Proteins 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000007423 decrease Effects 0.000 description 1
• 230000032459 dedifferentiation Effects 0.000 description 1
• 230000007123 defense Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000003412 degenerative effect Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000001934 delay Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 235000019425 dextrin Nutrition 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 210000002451 diencephalon Anatomy 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 238000006471 dimerization reaction Methods 0.000 description 1
• 150000002016 disaccharides Chemical class 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 210000005064 dopaminergic neuron Anatomy 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 229920002549 elastin Polymers 0.000 description 1
• 210000002257 embryonic structure Anatomy 0.000 description 1
• 210000003989 endothelium vascular Anatomy 0.000 description 1
• 230000007071 enzymatic hydrolysis Effects 0.000 description 1
• 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 208000001780 epistaxis Diseases 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• 230000003628 erosive effect Effects 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 230000036251 extravasation Effects 0.000 description 1
• 108010067559 factor H receptors Proteins 0.000 description 1
• 108010052621 fas Receptor Proteins 0.000 description 1
• 102000018823 fas Receptor Human genes 0.000 description 1
• 210000005002 female reproductive tract Anatomy 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 239000003527 fibrinolytic agent Substances 0.000 description 1
• 230000004761 fibrosis Effects 0.000 description 1
• 108010034065 fibulin 2 Proteins 0.000 description 1
• 210000003194 forelimb Anatomy 0.000 description 1
• 230000033581 fucosylation Effects 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 210000004907 gland Anatomy 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
• 230000002710 gonadal effect Effects 0.000 description 1
• 210000002503 granulosa cell Anatomy 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 229940093915 gynecological organic acid Drugs 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 230000023597 hemostasis Effects 0.000 description 1
• 229960001340 histamine Drugs 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 102000054366 human GPA33 Human genes 0.000 description 1
• 102000056573 human MYB Human genes 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 210000003917 human chromosome Anatomy 0.000 description 1
• 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 229940099552 hyaluronan Drugs 0.000 description 1
• KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
• 229960003160 hyaluronic acid Drugs 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 229920001477 hydrophilic polymer Polymers 0.000 description 1
• 238000002169 hydrotherapy Methods 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000008105 immune reaction Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 238000012296 in situ hybridization assay Methods 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 230000000302 ischemic effect Effects 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 201000002215 juvenile rheumatoid arthritis Diseases 0.000 description 1
• 210000001117 keloid Anatomy 0.000 description 1
• 108010042502 laminin A Proteins 0.000 description 1
• 108010009114 laminin beta2 Proteins 0.000 description 1
• 230000023404 leukocyte cell-cell adhesion Effects 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 231100000515 lung injury Toxicity 0.000 description 1
• 210000003563 lymphoid tissue Anatomy 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 210000001161 mammalian embryo Anatomy 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 235000013372 meat Nutrition 0.000 description 1
• 210000002891 metencephalon Anatomy 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 150000002772 monosaccharides Chemical class 0.000 description 1
• 230000021332 multicellular organism growth Effects 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 210000001989 nasopharynx Anatomy 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 210000005170 neoplastic cell Anatomy 0.000 description 1
• 239000003900 neurotrophic factor Substances 0.000 description 1
• 239000002736 nonionic surfactant Substances 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 239000002853 nucleic acid probe Substances 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 210000000287 oocyte Anatomy 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
• 230000011164 ossification Effects 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 210000001986 peyer's patch Anatomy 0.000 description 1
• 239000008177 pharmaceutical agent Substances 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 108010004568 plant pathogenesis-related proteins Proteins 0.000 description 1
• 230000007505 plaque formation Effects 0.000 description 1
• 210000004180 plasmocyte Anatomy 0.000 description 1
• 229920001983 poloxamer Polymers 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 208000030761 polycystic kidney disease Diseases 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 238000010837 poor prognosis Methods 0.000 description 1
• 235000020004 porter Nutrition 0.000 description 1
• 108010090646 preprocathepsin B Proteins 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• 230000005522 programmed cell death Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 210000004129 prosencephalon Anatomy 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 230000020978 protein processing Effects 0.000 description 1
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 238000002278 reconstructive surgery Methods 0.000 description 1
• 230000028646 regulation of complement activation Effects 0.000 description 1
• 238000004153 renaturation Methods 0.000 description 1
• 208000037803 restenosis Diseases 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 235000009566 rice Nutrition 0.000 description 1
• 210000005212 secondary lymphoid organ Anatomy 0.000 description 1
• 229960002101 secretin Drugs 0.000 description 1
• OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
• 102000015340 serglycin Human genes 0.000 description 1
• 108010050065 serglycin Proteins 0.000 description 1
• SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
• 229910052709 silver Inorganic materials 0.000 description 1
• 239000004332 silver Substances 0.000 description 1
• FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 239000012064 sodium phosphate buffer Substances 0.000 description 1
• 229940048086 sodium pyrophosphate Drugs 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 238000009987 spinning Methods 0.000 description 1
• 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 230000002311 subsequent effect Effects 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 150000005846 sugar alcohols Chemical class 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 210000001587 telencephalon Anatomy 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
• 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• 229940094937 thioredoxin Drugs 0.000 description 1
• 229960000103 thrombolytic agent Drugs 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000010474 transient expression Effects 0.000 description 1
• 102000027257 transmembrane receptors Human genes 0.000 description 1
• 108091008578 transmembrane receptors Proteins 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
• 229940038773 trisodium citrate Drugs 0.000 description 1
• 239000000439 tumor marker Substances 0.000 description 1
• 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 230000002485 urinary effect Effects 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 208000019553 vascular disease Diseases 0.000 description 1
• 230000008728 vascular permeability Effects 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1
• 208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 description 1